FETUIN-A, INDOXYLY SULFATE, VITAMIN K ANTAGONISTS EFFECTS ON VASCULAR CALCIFICATION AND AVF: A SYSTEMATIC REVIEW
Journal Title: European Journal of Pharmaceutical and Medical Research - Year 2019, Vol 6, Issue 7
Abstract
Background: Vascular calcification (VC) is a surrogate marker of vascular health. Functional vitamin K antagonists (VKA), fetuin-a and indoxyl sulfate (IS), are reported to have impacts on vascular calcification and may have clinical potential to modify the progression of vascular calcification and arteriovenous fistula failure status in the end stage renal disease. Methods: Studies evaluating the relationship of VKA, Fetuin-A, and IS with VC by at least stating one of the circulating compounds in animal models or patients either with CKD or patients receiving regular hemodialysis or on AVF were systematically identified. We searched English literature from January 1990 to November 2018 on the online MEDLINE and EMBASE. Results: Eight studies comprising a combined population of 2,766 participants were included after screening 449 distinctive abstracts. The included studies examined VKA, fetuin-a, IS effect on VC, and AVF. Conclusion: This paper is the first systematic review of the effect of vitamin K antagonists, Fetuin-A and IS status in VC and AVF. Our results suggest the quantification of the non-functional fractions of fetuin-a, IS, and VKA advocates their potential for detecting specific vascular calcification development in several patient cohorts. Lower fetuin-a levels and VKA in CKD subjects was linked to AVF failure. Further, studies with larger sample sizes are needed to enlighten whether their assessment can be of any clinical significance.
Authors and Affiliations
Dr. Li-Jun Yao
A RANDOMIZED, MULTIPLE-DOSE, MULTICENTER, COMPARATIVE PARALLEL STUDY TO EVALUATE THE PHARMACOKINETIC CHARACTERISTICS OF INTRAVENOUS INFUSION OF RITUXIMAB (HETERO) AND REFERENCE MEDICINAL PRODUCT (RITUXIMAB, ROCHE) IN INDIAN PATIENTS OF NON-HODGKIN'S LYMPHOMA
Aim: To evaluate the pharmacokinetic characteristics of two formulations of Rituximab (test and reference) at 1st & 6th cycles (steady state) of chemotherapy. Methods: A total of 135 Diffuse Large B-cell Lymphoma (DLBCL)...
BIOAVAILABILITY AND BIOEQUIVALENCE EVALUATION OF LOKMAL® (ARTEMETHER-LUMEFANTRINE 80/480 MG FIXED DOSE TABLET): AN EMZOR® PHARMACEUTICAL PRODUCT
Present design evaluated the bioavailability and bioequivalence of generic product of artemether - lumefantrine (AL) antimalarial fixed dose tablet which presents as Lokmal® 80/480 mg an Emzor® Pharmaceutical brand formu...
PYRUVATE KINASE ISOFORM M2 AS A DIAGNOSTIC TOOL FOR RENAL CELL CARCINOMA
Renal cell carcinoma (RCC) is the most common cancer in the kidney. Pyruvate kinase is an enzyme that catalyzes the conversion of phosphoenol pyruvate and ADP to pyruvate and ATP in glycolysis. Aim of the study: The curr...
OPTIC COHERENCE TOMOGRAPHY RESULTS IN PATIENTS WITH BEHÇET’S DISEASE
Significance: Retina is considered to be an easily traceable part of the brain. Even though the retina does not contain myelin, it is an ideal model of neuronal tissue where degeneration of the ganglion cell neurons and...
THE PROGNOSTIC FACTORS OF COMMUNITY-ACQUIRED BACTERIAL MENINGITIS IN ADULTS.
Backgrund and aims: Bacterial meningitis is a medical emergency whose prognosis is closely linked to the early management of the disease. The aim of our study is to determine the prognostic factors of community-acquired...